AWaRe ANTIBIOTIC SURVEILLANCE MANAGEMENT AND TREATMENT DOCUMENTATION IN INPATIENT MEDICATION THERAPY MONITORING

Main Article Content

Ariska Defy Anggarany
Fransiskus Samuel Renaldi
Rifaldi Saputra
Hanifah Irmayani
Deskia Amanda Fitriyani
Dina Putri Sri Utami
Zeashafa Zafira Ramdhan
Ghifa Amelia Syam Marissa Azi

Abstract

Background. Medication therapy monitoring can support antibiotic surveillance if records distinguish treatment decisions from pharmacy transactions.


Research Purpose. To describe the Access, Watch and Reserve profile of documented inpatient antibiotics, assess the traceability of treatment decisions, and determine how including antibiotics identified only in billing changed the profile.


Research Method. A retrospective descriptive audit screened inpatient forms from an Indonesian district hospital. We classified each charted systemic antibiotic outside tuberculosis regimens once per admission, assessed documentation from initiation to discharge, and repeated the classification with additional agents found only in billing records.


Findings. Fifteen episodes were screened. Nine met the criteria and contributed fourteen distinct combinations of episode and antibiotic. Watch antibiotics predominated, with ceftriaxone most frequent. All absent or conflicting start dates concerned Watch agents. Only one explicit stop date was found and it conflicted with the narrative. No documented review could be traced through to implementation. Adding antibiotics identified only in billing increased the Watch share.


Conclusion. The audit identifies third generation cephalosporins as a local priority for stewardship review. Linking treatment decisions to orders and administration records would help verify implementation and clarify discrepancies at discharge.

Article Details

How to Cite
Anggarany, A. D., Renaldi, F. S., Saputra, R., Irmayani, H., Fitriyani, D. A., Utami, D. P. S., Ramdhan, Z. Z., & Azi, G. A. S. M. (2026). AWaRe ANTIBIOTIC SURVEILLANCE MANAGEMENT AND TREATMENT DOCUMENTATION IN INPATIENT MEDICATION THERAPY MONITORING. DIVERSITY Logic Journal Multidisciplinary, 4(3), 288–300. https://doi.org/10.61543/diversity.v4i3.214
Section
Articles

References

GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–1226. doi:10.1016/S0140-6736(24)01867-1.

World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) report: antibiotic use data for 2022 [Internet]. Geneva: World Health Organization; 2025 [cited 2026 Nov 13]. Available from: https://www.who.int/publications/i/item/9789240108127

World Health Organization. The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use [Internet]. Geneva: World Health Organization; 2025 [cited 2026 Nov 13]. Available from: https://www.who.int/publications/i/item/B09489

Zanichelli V, Sharland M, Cappello B, Moja L, Getahun H, Pessoa-Silva CL, et al. The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance. Bull World Health Organ. 2023;101(4):290–296. doi:10.2471/BLT.22.288614.

Limato R, Lazarus G, Dernison P, Mudia M, Alamanda M, Nelwan EJ, et al. Optimizing antibiotic use in Indonesia: a systematic review and evidence synthesis to inform opportunities for intervention. Lancet Reg Health Southeast Asia. 2022;2:100013. doi:10.1016/j.lansea.2022.05.002.

Sinto R, Limato R, Radiani SP, Huda MN, Surendra H, Praptiwi AW, et al. A nationwide mixed-methods study of gaps and barriers to implementation of antimicrobial stewardship programmes in hospitals in Indonesia. J Hosp Infect. 2024;154:77–87. doi:10.1016/j.jhin.2024.10.001.

Qibtiyah M, Safiro A, Damayanti A, Rusli M, Parathon H, Hadi U, et al. Quantity and quality of antibiotic use in surgical and medical wards in a general academic hospital: a retrospective study. Pol J Microbiol. 2026;75(1):3–10. doi:10.33073/pjm-2026-002.

Natadidjaja RI, Lekok W, Marja TS, Adlani H, Ariyani A, Mulyani S, et al. The appropriateness of initial intravenous empirical antibiotic consumption guided by digital antimicrobial stewardship tool: a correlation with the usage of antibiotics from the access and watch groups in ten Indonesian hospitals. Front Digit Health. 2026;8:1862829. doi:10.3389/fdgth.2026.1862829.

Vu MD, Duong HY, Vu TVD, Nguyen TCT, Nguyen HY, Nguyen HK, et al. Antimicrobial use in referral hospitals in Viet Nam: a multi-center point prevalence survey. Int J Infect Dis. 2026;170:108921. doi:10.1016/j.ijid.2026.108921.

Monnier AA, D’Onofrio V, Willemsen I, Kluytmans-van den Bergh MFQ, Kluytmans JAJW, Schuermans A, et al. Practice testing of generic quality indicators for responsible antibiotic use in nine hospitals in the Dutch–Belgian border area. J Hosp Infect. 2022;129:153–161. doi:10.1016/j.jhin.2022.07.030.

Walker K, Harding AM, Tran J, Wembridge P, Garrett K, MacMillan K, et al. Medication not accounted for in hospital electronic medication administration records: a retrospective observational study. Med J Aust. 2022;216(5):248–254. doi:10.5694/mja2.51370.

Pemerintah Kabupaten Bogor. Peraturan Bupati Bogor Nomor 36 Tahun 2025 tentang Perubahan Nama Rumah Sakit Umum Daerah Cibinong Menjadi Rumah Sakit Umum Daerah Bakti Pajajaran [Internet]. Cibinong: Pemerintah Kabupaten Bogor; 2025 [cited 2026 Nov 13]. Available from: https://jdih.bogorkab.go.id/peraturan/peraturan_bupati/show/2664

UK Health Security Agency. Start smart then focus: antimicrobial stewardship toolkit for inpatient care settings [Internet]. London: UK Health Security Agency; 2023 [cited 2026 Nov 13]. Available from: https://www.gov.uk/government/publications/antimicrobial-stewardship-start-smart-then-focus/start-smart-then-focus-antimicrobial-stewardship-toolkit-for-inpatient-care-settings

Centers for Disease Control and Prevention. National Healthcare Safety Network patient safety component manual: antimicrobial use and resistance module [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2026 [cited 2026 Nov 13]. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/11pscaurcurrent.pdf

Kusuma IY, Benk? R, Papfalvi EP, Dewi NMAR, Nurkholis F, Nacsa R, et al. Antibiotic use in the emergency department: a retrospective study in Indonesia. Antibiotics (Basel). 2026;15(4):401. doi:10.3390/antibiotics15040401.

Boven A, Ivanova A, Versporten A, Pauwels I, Bo R, Garcia J, et al. Identifying hospital-level predictors for antibiotic use: a Global Point Prevalence Survey study among Belgian, Philippine and South African hospitals. JAC Antimicrob Resist. 2026;8(2):dlag042. doi:10.1093/jacamr/dlag042.

Harrison ML, Dickson BFR, Villanueva-Uy MET, Putri ND, Adrizain R, Kartina L, et al. High rates of “Watch” and “Reserve” class antibiotics used to treat infections in neonates and infants in Southeast Asia. Pediatr Infect Dis J. 2025;44(4):e113–e116. doi:10.1097/INF.0000000000004614.

Sakai M, Sakai T, Watariguchi T, Kawabata A, Shirai M, Kakimoto M, et al. Development and validation of an automated antimicrobial surveillance system based on indications for antimicrobial administration. J Infect Chemother. 2025;31(1):102472. doi:10.1016/j.jiac.2024.07.012.

Llewelyn MJ, Budgell EP, Laskawiec-Szkonter M, Cross ELA, Alexander R, Bond S, et al. Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial. Lancet Infect Dis. 2023;23(2):207–221. doi:10.1016/S1473-3099(22)00508-4.

Chikeka K, Gbadamosi K, Tran H, Chughtai I, Muhammad S, Senay M, et al. Pilot study: impact of a pharmacist-led 48-hour antibiotic time-out on antibiotic utilization and outcome measures in a community teaching hospital. Hosp Pharm. 2023;58(3):277–281. doi:10.1177/00185787221139429.

Moehring RW, Yarrington ME, Warren BG, Lokhnygina Y, Atkinson E, Bankston A, et al. Evaluation of an opt-out protocol for antibiotic de-escalation in patients with suspected sepsis: a multicenter, randomized, controlled trial. Clin Infect Dis. 2023;76(3):433–442. doi:10.1093/cid/ciac787.

Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/2147/2023 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Pneumonia pada Dewasa [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2023 [cited 2026 Nov 13]. Available from: https://jdih.kemkes.go.id/documents/keputusan-menteri-kesehatan-nomor-hk0107menkes21472023

Jones BE, Ramirez JA, Oren E, Soni NJ, Sullivan LR, Restrepo MI, et al. Diagnosis and management of community-acquired pneumonia: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2026;212(1):24–44. doi:10.1164/rccm.202507-1692ST.

Furukawa Y, Luo Y, Funada S, Onishi A, Ostinelli EG, Hamza T, et al. Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis. BMJ Open. 2023;13(3):e061023. doi:10.1136/bmjopen-2022-061023.

Williams DJ, Creech CB, Walter EB, Martin JM, Gerber JS, Newland JG, et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr. 2022;176(3):253–261. doi:10.1001/jamapediatrics.2021.5547.

de Brabander J, Nelwan EJ, Limato R, Alamanda M, Mudia M, Tjoa E, et al. Aetiology and antibiotic susceptibility of common bacterial infections in hospitalised patients: a 2019 multisite cross-sectional survey in Jakarta, Indonesia. Trop Med Int Health. 2026;31(9):1231–1237. doi:10.1111/tmi.70162.

Woods-Hill CZ, Colantuoni EA, Koontz DW, Voskertchian A, Xie A, Thurm C, et al. Association of diagnostic stewardship for blood cultures in critically ill children with culture rates, antibiotic use, and patient outcomes: results of the Bright STAR Collaborative. JAMA Pediatr. 2022;176(7):690–698. doi:10.1001/jamapediatrics.2022.1024.

Fanella S, Bitnun A, Barton M, Sauvé L. Diagnosis and management of congenital syphilis: avoiding missed opportunities. Paediatr Child Health. 2024;29(7):463–479. doi:10.1093/pch/pxae044.

Hikma Pharmaceuticals USA Inc. Furosemide injection: prescribing information [Internet]. Berkeley Heights (NJ): Hikma Pharmaceuticals USA Inc.; 2024 [cited 2026 Nov 13]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/018267s029lbl.pdf

Harvey EJ, Hand K, Weston D, Ashiru-Oredope D. Development of national antimicrobial intravenous-to-oral switch criteria and decision aid. J Clin Med. 2023;12(6):2086. doi:10.3390/jcm12062086.

Harvey EJ, McLeod M, De Brún C, Ashiru-Oredope D. Criteria to achieve safe antimicrobial intravenous-to-oral switch in hospitalised adult populations: a systematic rapid review. BMJ Open. 2023;13(7):e068299. doi:10.1136/bmjopen-2022-068299.

Daniels L, Heintz B, Lund B, Alexander B, Livorsi D. Frequency of intravenous-to-oral antibiotic switch in VA hospitalized patients with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2026;47(4):365–372. doi:10.1017/ice.2025.10389.

Livorsi DJ, Thompson AM, Green MS, Hoelscher AC, Chu KK, Neuner E, et al. Prospective audit and feedback by antibiotic stewardship teams to reduce antibiotic overuse at hospital discharge: a stepped-wedge cluster-randomized clinical trial. JAMA Netw Open. 2026;9(1):e2549655. doi:10.1001/jamanetworkopen.2025.49655.

Jošt M, Knez L, Kos M, Kerec Kos M. Pharmacist-led hospital intervention reduces unintentional patient-generated medication discrepancies after hospital discharge. Front Pharmacol. 2024;15:1483932. doi:10.3389/fphar.2024.1483932.

Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, et al. Stewardship prompts to improve antibiotic selection for pneumonia: the INSPIRE randomized clinical trial. JAMA. 2024;331(23):2007–2017. doi:10.1001/jama.2024.6248.

Catho G, Sauser J, Coray V, Da Silva S, Elzi L, Harbarth S, et al. Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitals. Lancet Infect Dis. 2022;22(10):1493–1502. doi:10.1016/S1473-3099(22)00308-5.